“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope Rugo

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope Rugo

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatmentsПодробнее

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatments

Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General SessionПодробнее

Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General Session

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast CancerПодробнее

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast CancerПодробнее

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast Cancer

Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast Cancer

TROPiCS-02 shows sacituzumab govitecan OS benefit in HR+, HER2– advanced breast cancer | Hope RugoПодробнее

TROPiCS-02 shows sacituzumab govitecan OS benefit in HR+, HER2– advanced breast cancer | Hope Rugo

Breast Cancer: The Next Wave By Dr. Hope RugoПодробнее

Breast Cancer: The Next Wave By Dr. Hope Rugo

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast CancerПодробнее

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast Cancer

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast Cancer

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer ManagementПодробнее

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer Management

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breast CancerПодробнее

Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breast Cancer

Hope Rugo, MD: Chemotherapy Agents and Breast Cancer TreatmentПодробнее

Hope Rugo, MD: Chemotherapy Agents and Breast Cancer Treatment

Dr. Hope S. Rugo: Reducing Hair Loss in Breast Cancer PatientsПодробнее

Dr. Hope S. Rugo: Reducing Hair Loss in Breast Cancer Patients

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast Cancer

Hope Rugo, MD, offers key takeaways for physicians regarding KEYNOTE-355Подробнее

Hope Rugo, MD, offers key takeaways for physicians regarding KEYNOTE-355

Dr. Rugo on Guidelines for the Treatment of Metastatic Breast CancerПодробнее

Dr. Rugo on Guidelines for the Treatment of Metastatic Breast Cancer

Dr. Rugo on the Significance of the MONARCH I Trial for Breast CancerПодробнее

Dr. Rugo on the Significance of the MONARCH I Trial for Breast Cancer

Dr. Rugo on Targeted Agents in Biologic Subsets of Breast CancerПодробнее

Dr. Rugo on Targeted Agents in Biologic Subsets of Breast Cancer

Актуальное